Black Rock Inc. Phio Pharmaceuticals Corp. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.64 - $2.35 $22,288 - $81,838	-34,825 Reduced 99.95%	19 $0
Q1 2022 May 12, 2022	SELL	$0.73 - $1.1 $1,228 - $1,851	-1,683 Reduced 4.61%	34,844 $31,000
Q4 2021 Feb 10, 2022	BUY	$0.99 - $1.99 $925 - $1,860	935 Added 2.63%	36,527 $37,000
Q3 2021 Nov 09, 2021	SELL	$1.62 - $2.28 $12,527 - $17,631	-7,733 Reduced 17.85%	35,592 $72,000
Q2 2021 Aug 11, 2021	BUY	$1.87 - $2.8 $81,017 - $121,309	43,325 New	43,325 $98,000

Ticker PHIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,658,700
Market Cap $47.8M
Description
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.